HIV / AIDS in the News

Dining Out For Life supports local HIV care in Milwaukee - WISN

 

Does Expanded HIV Prevention Access Change The Bull Case For Gilead Stock (GILD)? - simplywall.st

 

HIV cases in SF fall 8%, resume their downward trend - Bay Area Reporter

 

State HIV Prevention Policies May Benefit Racial and Ethnic Groups Unequally - Annenberg Public Policy Center

 

Injectable HIV Treatment Beats Daily Pills in Adolescent Trial - Drug Topics

 

Rutgers, Weill Cornell Medicine awarded $3M to study HIV’s effects on the brain - ROI-NJ

 

In A 'Different World' For HIV Patients, Debbie Allen & Merck Launch 'Hive' Campaign 09/24/2026 - MediaPost

 

HIV Infection Tied to Liver Fibrosis in Women With SLD - medscape.com

 

Harold Phillips: Don't let access to HIV prevention slip away (Opinion) - herald-dispatch.com

 

Multifocal Inflammatory Pseudotumor Involving the Orbit, Skull Base, and Cauda Equina Causing Progressive Visual Loss in a Patient With HIV Infection: A Case Report - cureus.com

 

Creative Biolabs Expands Antibody Portfolio for HIV and HTLV Research - 24-7 Press Release Newswire

 

Fiji's HIV epidemic is surging and babies are paying the price - ABC News & Headlines – Australian Broadcasting Corporation

 

Willamette Week: 1 hailed, 1 going to prison in work for HIV treatment - KATU

 

Harold Phillips: Don't let access to HIV prevention slip away (Opinion) - Charleston Gazette-Mail

 

Modified HIV Drug Reverses MS Vision Loss, Paralysis - Mirage News

 

Atomo Diagnostics: Revenue up 41% and EBITDA improved 39%, with strong HIV and OEM growth and a robust pipeline - TradingView

 

‘My biggest fear is that he will die in there’: Cuban detainee with HIV reports ‘inhumane’ treatment at ICE facility in Miramar - WPLG Local 10

 

Cuban man reports ICE denied him HIV meds - WPLG Local 10

 

POZ | Most people with HIV are willing to switch to long-acting treatment - European AIDS Treatment Group

 

University of California, Riverside | Target identified in treatment of neuroHIV - European AIDS Treatment Group

 

Healio | Trial backs use of lenacapavir for pregnant, postpartum women - European AIDS Treatment Group

 

Rutgers and Weill Cornell Medicine Win $3 Million to Study HIV’s Toll on the Brain | Newswise - Newswise

 

In A 'Different World' For HIV Patients, Debbie Allen & Merck Launch 'Hive' Campaign 09/24/2026 - MediaPost

 

In A 'Different World' For HIV Patients, Debbie Allen & Merck Launch 'Hive' Campaign - Yahoo

 

Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha

 

LGBTQ Agenda: GLAAD tackles HIV stigma as Gen Z admits to not feeling informed about virus - ebar.com

 

US Judge Signals He May Block Trump HIV Funding Restrictions on Transgender Care - Межа. Новини України.

 

Most People With HIV Are Willing to Switch to Long-Acting Treatment - POZ

 

Debbie Allen on HIV Advocacy, Black Storytelling, and the Next Chapter of A Different World - Black Health Matters

 

Rutgers and Weill Cornell Medicine Win $3 Million to Study HIV’s Toll on the Brain - Rutgers University